• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调蛋白参与胰高血糖素样肽1(7 - 36)酰胺对小鼠胰腺β细胞中ATP敏感性钾通道的抑制作用。

Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.

作者信息

Ding W G, Kitasato H, Matsuura H

机构信息

Department of Physiology, Shiga University of Medical Science, Shiga 520-2192, Japan.

出版信息

Exp Physiol. 2001 May;86(3):331-9. doi: 10.1113/eph8602173.

DOI:10.1113/eph8602173
PMID:11429650
Abstract

The present investigation was designed to examine whether calmodulin is involved in the inhibition of the ATP-sensitive K+ (K(ATP)) channel by glucagon-like peptide 1(7-36) amide (GLP-1) in mouse pancreatic beta-cells. Membrane potential, single channel and whole-cell currents through the K(ATP) channels, and intracellular free Ca2+ concentration ([Ca2+]i) were measured in single mouse pancreatic beta-cells. Whole-cell patch-clamp experiments with amphotericin-perforated patches revealed that membrane conductance at around the resting potential is predominantly supplied by the K(ATP) channels in mouse pancreatic beta-cells. The addition of 20 nM GLP-1 in the presence of 5 mM glucose significantly reduced the membrane K(ATP) conductance, accompanied by membrane depolarization and the generation of electrical activity. A calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalenesulphonamide (W-7, 20 microM) completely reversed the inhibitory actions of GLP-1 on the membrane K(ATP) conductance and resultant membrane depolarization. Cell-attached patch recordings confirmed the inhibition of the K(ATP) channel activity by 20 nM GLP-1 and its restoration by 20 microM W-7 or 10 microM calmidazolium at the single channel level. Bath application of 20 microM W-7 also consistently abolished the GLP-1-evoked increase in [Ca2+]i in the presence of 5 mM glucose. These results strongly suggest that the mechanisms by which GLP-1 inhibits the K(ATP) channel activity accompanied by the initiation of electrical activity in mouse pancreatic beta-cells include a calmodulin-dependent mechanism in addition to the well-documented activation of the cyclic AMP-protein kinase A system.

摘要

本研究旨在探讨在小鼠胰腺β细胞中,钙调蛋白是否参与胰高血糖素样肽1(7 - 36)酰胺(GLP - 1)对ATP敏感性钾通道(K(ATP)通道)的抑制作用。在单个小鼠胰腺β细胞中测量了膜电位、通过K(ATP)通道的单通道电流和全细胞电流,以及细胞内游离Ca2+浓度([Ca2+]i)。用两性霉素穿孔膜片进行的全细胞膜片钳实验表明,在小鼠胰腺β细胞静息电位附近,膜电导主要由K(ATP)通道提供。在5 mM葡萄糖存在的情况下,加入20 nM GLP - 1可显著降低膜K(ATP)电导,同时伴有膜去极化和电活动的产生。钙调蛋白抑制剂N-(6 - 氨基己基)-5 - 氯-1 - 萘磺酰胺(W - 7,20 μM)完全逆转了GLP - 1对膜K(ATP)电导的抑制作用以及由此导致的膜去极化。细胞贴附式膜片记录证实,在单通道水平上,20 nM GLP - 1可抑制K(ATP)通道活性,而20 μM W - 7或10 μM钙调蛋白拮抗剂可使其恢复。在5 mM葡萄糖存在的情况下,浴槽中加入20 μM W - 7也始终消除了GLP - 1引起的[Ca2+]i升高。这些结果强烈表明,在小鼠胰腺β细胞中,GLP - 1抑制K(ATP)通道活性并引发电活动的机制,除了已充分证明的环磷酸腺苷 - 蛋白激酶A系统激活外,还包括一种钙调蛋白依赖性机制。

相似文献

1
Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.钙调蛋白参与胰高血糖素样肽1(7 - 36)酰胺对小鼠胰腺β细胞中ATP敏感性钾通道的抑制作用。
Exp Physiol. 2001 May;86(3):331-9. doi: 10.1113/eph8602173.
2
Glucagon induces suppression of ATP-sensitive K+ channel activity through a Ca2+/calmodulin-dependent pathway in mouse pancreatic beta-cells.胰高血糖素通过Ca2+/钙调蛋白依赖性途径抑制小鼠胰腺β细胞中ATP敏感性钾通道的活性。
J Membr Biol. 1998 Dec 1;166(3):237-44. doi: 10.1007/s002329900465.
3
cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 in rat pancreatic beta-cells.胰高血糖素样肽-1对大鼠胰岛β细胞ATP敏感性钾通道活性的非cAMP依赖性降低作用
Pflugers Arch. 2000 Aug;440(4):566-72. doi: 10.1007/s004240000279.
4
Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.胰高血糖素样肽1(7-36)酰胺通过刺激-分泌偶联中的近端和远端调节步骤刺激人胰岛β细胞的胞吐作用。
Diabetes. 1998 Jan;47(1):57-65. doi: 10.2337/diab.47.1.57.
5
GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.胰高血糖素样肽-1(7-36)酰胺以环磷酸腺苷(cAMP)依赖的方式增强大鼠胰岛β细胞L型钙通道的钡离子电流。
Diabetes. 1997 Nov;46(11):1755-60. doi: 10.2337/diab.46.11.1755.
6
Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.环磷酸腺苷(cAMP)升高激动剂对胰岛素分泌的多部位调节:胰高血糖素样肽1和胰高血糖素通过不同受体起作用的证据。
Pflugers Arch. 1997 Sep;434(5):515-24. doi: 10.1007/s004240050431.
7
Glucagon-like peptide-1 modulates Ca2+ current but not K+ATP current in intact mouse pancreatic B-cells.胰高血糖素样肽-1调节完整小鼠胰腺β细胞中的Ca2+电流,但不调节K+ATP电流。
Biochem Biophys Res Commun. 1995 Feb 6;207(1):33-9. doi: 10.1006/bbrc.1995.1149.
8
A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells.一种新型降糖药A - 4166可抑制大鼠胰腺β细胞中的ATP敏感性钾通道。
Am J Physiol. 1995 Feb;268(2 Pt 1):E185-93. doi: 10.1152/ajpendo.1995.268.2.E185.
9
Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway.胰岛素通过磷脂酰肌醇3激酶依赖性途径激活胰腺β细胞中的ATP敏感性钾通道。
Diabetes. 2001 Oct;50(10):2192-8. doi: 10.2337/diabetes.50.10.2192.
10
Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.胰高血糖素样肽-1-(7-36)酰胺以及环磷酸腺苷水平的升高通过增强钙离子通道活性来增加大鼠胰腺β细胞中的胞质游离钙离子浓度。
Endocrinology. 1993 Oct;133(4):1685-92. doi: 10.1210/endo.133.4.8404610.

引用本文的文献

1
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.肽类是未来的心脏保护药物:胰高血糖素样肽-1 受体激动剂心脏保护作用的受体和信号转导机制。
Int J Mol Sci. 2024 Apr 30;25(9):4900. doi: 10.3390/ijms25094900.
2
Leptin-stimulated KATP channel trafficking: a new paradigm for β-cell stimulus-secretion coupling?瘦素刺激的ATP敏感性钾通道转运:β细胞刺激-分泌偶联的新范式?
Islets. 2013 Sep-Dec;5(5):229-32. doi: 10.4161/isl.26958. Epub 2013 Nov 8.
3
Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac.
环腺苷酸类似物通过选择性作用于环腺苷酸调节的鸟嘌呤核苷酸交换因子 Epac 促进 β 细胞 KATP 通道磺酰脲敏感性。
Islets. 2010 Mar-Apr;2(2):72-81. doi: 10.4161/isl.2.2.10582.
4
PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.蛋白激酶 A 依赖性激动剂 8-pCPT-2'-O-Me-cAMP-AM 增强人胰岛中葡萄糖刺激的胰岛素分泌。
Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E622-33. doi: 10.1152/ajpendo.00630.2009. Epub 2009 Dec 15.
5
Suppressed Ca2+/CaM/CaMKII-dependent K(ATP) channel activity in primary afferent neurons mediates hyperalgesia after axotomy.初级传入神经元中受抑制的Ca2+/钙调蛋白/钙调蛋白依赖性蛋白激酶II依赖的ATP敏感性钾通道活性介导了轴突切断后的痛觉过敏。
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8725-30. doi: 10.1073/pnas.0901815106. Epub 2009 May 13.
6
Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells.环磷酸腺苷(cAMP)传感器交换蛋白直接激活cAMP(Epac)作为人胰岛β细胞和大鼠胰岛瘤INS-1细胞中ATP敏感性钾通道(KATP通道)ATP敏感性决定因素的作用。
J Physiol. 2008 Mar 1;586(5):1307-19. doi: 10.1113/jphysiol.2007.143818. Epub 2008 Jan 17.
7
cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.环磷酸腺苷(cAMP)传感器Epac作为人胰岛β细胞和大鼠INS-1细胞中三磷酸腺苷(ATP)敏感性钾通道活性的一个决定因素。
J Physiol. 2006 Jun 15;573(Pt 3):595-609. doi: 10.1113/jphysiol.2006.107391. Epub 2006 Apr 13.
8
Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.胰高血糖素样肽-1合成类似物:用于治疗糖尿病的新型治疗药物。
Curr Med Chem. 2003 Nov;10(22):2471-83. doi: 10.2174/0929867033456648.
9
Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220.艾塞那肽-4作为大鼠胰岛素I基因启动子活性的刺激因子,通过对丝氨酸/苏氨酸蛋白激酶抑制剂Ro 31-8220敏感的bZIP/CRE相互作用发挥作用。
Endocrinology. 2002 Jun;143(6):2303-13. doi: 10.1210/endo.143.6.8870.